Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials

Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data... Gastric Cancer (2017) 20:757–763 DOI 10.1007/s10120-017-0702-0 ORIGINAL ARTICLE Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials 1 2 3 4 • • • • Daisuke Takahari Junki Mizusawa Wasaburo Koizumi Ichinosuke Hyodo Narikazu Boku Received: 25 December 2016 / Accepted: 5 February 2017 / Published online: 16 February 2017 The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2017 Abstract demonstrated highly significant survival differences; the Background In a phase III study for advanced gastric hazard ratios (95% confidence interval) were 1.71 cancer (AGC), the Japan Clinical Oncology Group (JCOG) (1.46–2.01) between the good (n = 338) and moderate 9912 trial, we previously identified the following four (n = 537) risk groups and 3.32 (2.47–4.46) between good prognostic factors—performance status C1, number of and poor (n = 61) risk groups. The median overall survival metastatic sites C2, no prior gastrectomy, and abnormal times of the good, moderate, and poor risk groups were serum alkaline phosphatase levels—and proposed a prog- 17.2, 12.0, and 7.8 months, respectively. nostic index (good risk with 0 or 1 factor, moderate risk Conclusions The JCOG prognostic index was externally with 2 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Gastric Cancer Springer Journals

Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials

Loading next page...
 
/lp/springer_journal/validation-of-the-jcog-prognostic-index-in-advanced-gastric-cancer-OAnr334u80
Publisher
Springer Japan
Copyright
Copyright © 2017 by The International Gastric Cancer Association and The Japanese Gastric Cancer Association
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Abdominal Surgery; Gastroenterology; Cancer Research
ISSN
1436-3291
eISSN
1436-3305
D.O.I.
10.1007/s10120-017-0702-0
Publisher site
See Article on Publisher Site

Abstract

Gastric Cancer (2017) 20:757–763 DOI 10.1007/s10120-017-0702-0 ORIGINAL ARTICLE Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials 1 2 3 4 • • • • Daisuke Takahari Junki Mizusawa Wasaburo Koizumi Ichinosuke Hyodo Narikazu Boku Received: 25 December 2016 / Accepted: 5 February 2017 / Published online: 16 February 2017 The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2017 Abstract demonstrated highly significant survival differences; the Background In a phase III study for advanced gastric hazard ratios (95% confidence interval) were 1.71 cancer (AGC), the Japan Clinical Oncology Group (JCOG) (1.46–2.01) between the good (n = 338) and moderate 9912 trial, we previously identified the following four (n = 537) risk groups and 3.32 (2.47–4.46) between good prognostic factors—performance status C1, number of and poor (n = 61) risk groups. The median overall survival metastatic sites C2, no prior gastrectomy, and abnormal times of the good, moderate, and poor risk groups were serum alkaline phosphatase levels—and proposed a prog- 17.2, 12.0, and 7.8 months, respectively. nostic index (good risk with 0 or 1 factor, moderate risk Conclusions The JCOG prognostic index was externally with 2

Journal

Gastric CancerSpringer Journals

Published: Feb 16, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off